Bausch Health Companies Inc.
BHC
$6.25
-$0.07-1.11%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 303.37% | 120.81% | 91.21% | 92.23% | 81.52% |
| Total Depreciation and Amortization | -4.97% | -2.13% | -1.03% | 0.24% | -0.46% |
| Total Amortization of Deferred Charges | -25.00% | -22.73% | -34.09% | -15.38% | 81.25% |
| Total Other Non-Cash Items | -112.14% | -93.21% | -53.15% | -64.20% | -82.16% |
| Change in Net Operating Assets | -204.26% | 111.21% | 95.86% | 101.20% | 89.17% |
| Cash from Operations | 8.66% | 19.24% | 46.65% | 54.75% | 24.08% |
| Capital Expenditure | -24.92% | -30.33% | -48.00% | -56.74% | -79.78% |
| Sale of Property, Plant, and Equipment | 0.00% | -16.67% | 0.00% | 40.00% | -30.00% |
| Cash Acquisitions | -125.00% | 92.04% | 92.04% | 92.80% | 97.52% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 96.88% | 105.56% | 102.70% | 126.67% | -14.29% |
| Cash from Investing | -27.61% | 75.70% | 76.12% | 78.83% | 81.15% |
| Total Debt Issued | 3,530.23% | 265.36% | -80.19% | -79.91% | -91.40% |
| Total Debt Repaid | -798.56% | -462.20% | 32.02% | 14.62% | 41.19% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -12.50% | 0.00% | -7.69% | -8.33% | 0.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -26.32% | 3.49% | 49.43% | 47.56% | 17.39% |
| Cash from Financing | 59.11% | -88.90% | -152.78% | -158.85% | -180.75% |
| Foreign Exchange rate Adjustments | 5.56% | 416.67% | -400.00% | -500.00% | -14.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,066.67% | 3,100.00% | 79.46% | -35.58% | -110.60% |